Philips CEO Sees Doubling of Sales Growth Rate as Unlikely -- Market Talk

Dow Jones
2025/12/04

1012 GMT - While Philips expects organic sales growth to improve in 2026, doubling of the growth rate is unlikely, Chief Executive Roy Jakobs told Citi analysts at the Global Healthcare Conference. Philips saw growth improve 1% in 2024 and guides for around 2% in 2025, Citi analysts say in a research note. The Dutch health-technology company's call of caution means that organic sales growth should be more than 2% but less than 4%, compared with company-compiled consensus of 4.5%, Citi says. Jakobs said the company still expects margins to expand in 2026, but tariff impacts will almost double year-on-year, Citi notes. Nevertheless, Citi sees Philips on track, the analysts say. Shares trade 7.4% lower at 22.27 euros. (nina.kienle@wsj.com)

 

(END) Dow Jones Newswires

December 04, 2025 05:16 ET (10:16 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10